NEW YORK ( TheStreet) -- Valeant Pharmaceuticals International (NYSE: VRX) hit a new 52-week high Thursday as it is currently trading at $58.51, above its previous 52-week high of $57.24 with 532,302 shares traded as of 9:35 a.m. ET. Average volume has been 1.4 million shares over the past 30 days. Valeant Pharmaceuticals International has a market cap of $17.19 billion and is part of the health care sector and drugs industry. Shares are up 20.9% year to date as of the close of trading on Wednesday. Valeant Pharmaceuticals International, Inc., a specialty pharmaceutical company, develops, manufactures, and markets pharmaceutical products in the areas of neurology, dermatology, and branded generics. The company has a P/E ratio of 114.9, equal to the average drugs industry P/E ratio and above the S&P 500 P/E ratio of 17.7.
- Sign up for TheStreet's FREE Dividend and Income Investor Newsletter